The Claim
Atrial natriuretic peptide (ANP) treatment increases lipolysis seven-fold and oxygen consumption two-fold in differentiated human adipocytes by activating the alpha2 subunit of AMP-activated protein kinase (AMPK), indicating that ANP enhances lipid breakdown and mitochondrial activity in human fat cells under laboratory conditions.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
A hormone called ANP might supercharge fat cells in a lab, making them burn fat seven times more and use twice as much oxygen by turning on a specific energy sensor in the cell.
See the scientific wording
Atrial natriuretic peptide (ANP) treatment increases lipolysis by seven-fold and oxygen consumption by two-fold in differentiated human adipocytes through activation of the alpha2 subunit of AMP-activated protein kinase (AMPK), suggesting a role for ANP in enhancing lipid breakdown and mitochondrial activity in human fat cells in laboratory conditions.
What the research says
1 studyThe study shows that treating human fat cells with ANP boosts fat breakdown and energy use exactly as claimed, and explains how it works through a specific cellular pathway.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.